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Abstract
Functional foods provide health benefits if they are consumed on regular basis. Some
nutraceutical pet diets have been demonstrated to exert health benefits in vitro and in
vivo while also exhibiting palatability to the animals. The aim of this chapter is to provide
an overall  update of commercially available pet diets with proven efficacy against
pathologies with an inflammatory background. Research on pet food is still scarce and
biased. The ultimate success of functional pet foods will depend on delivering bioactive
components in a predictable and assured manner to effectively reduce the risk of disease
and/or support the body. Our investigations outlined the improved health status of sick
dogs by means of a commercially available nutraceutical pet diet approach. Therefore,
additional investigations into the consumption of functional foods in domestic animal
nutrition should be done in order to study dietary interventions for disease prevention
and treatment.
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1. Introduction
The interest in the efficacy and safety of pet food has been growing worldwide with vegetables,
whole grains, fortified active principles, fruits, probiotics, prebiotics, and herbal extracts as the
most effective substances available. In addition, the use of antibiotics in the agriculture and
intensive farming has also become a relevant concern with consequent potential health risks
derived by their entry/accumulation in human food and animal food supply chains.
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2. Antibiotic residues in pet food and adverse food reactions
In the last 35 years, a surprising increase of skin and gastrointestinal (GI) diseases in both cats
and dogs has been observed [1]. For instance, in vivo studies have widely demonstrated that
the most commonly responsible ingredients for the onset of cutaneous and gastrointestinal
adverse food reactions are beef, dairy products, wheat, and to some degree, lamb, soy, and
fish [2–5]. However, only in a few cases were such adverse food reactions clearly ascribed to
the presence of food additives such as dyes, preservatives, or even antibiotics [6–8].
One of the main symptoms of skin‐related diseases is severe itching, which may lead to self‐
inflicted injuries caused by obsessive scratching, while frequent gastrointestinal symptoms are
vomiting and diarrhea, which continue to persist after therapy. These phenomena suggest
paying particular attention to the history of several examined cases in order to determine their
primary and real cause.
We recently identified a specific compound, oxytetracycline (OTC), as the possible underly‐
ing cause of most inflammatory pathologies both in vitro [9, 10] and in vivo [11, 12]. OTC
belongs to the class of tetracyclines, which are the most widely and legally used antibiotics
in intensive farming, for example, poultry [10], livestock [13], and aquaculture [14], due to
their low cost and efficacy [15]. Unfortunately, OTC also has a high affinity for calcium‐rich
tissues such as bone and teeth [16] and can remain fixed for extended periods in treated
animals even respecting withdrawal time [10]. Moreover, pet food production relies on meat
(mainly poultry) by‐products, which are mechanically separated [17, 18]. This kind of sepa‐
ration, and the common use of important percentages of bone meal mixed with meat meal,
generates a bone‐based meal‐bearing OTC residues that is present in commercially available
diets (canned, semi‐moist, and especially dry) in a percentage of 20–30% and can accumu‐
late within pet's body.
Odore et al. and Di Cerbo et al. recently demonstrated the significant in vitro toxicity of milled
bone from chickens treated with OTC, either alone or diluted 1:4, toward peripheral blood
mononuclear cell (PBMC) culture (**p < 0.01 and ***p < 0.001, respectively) [9, 10]. Conversely,
bone derived by chickens untreated with OTC did not show any cytotoxic effect (Figure 1).
Furthermore, Di Cerbo et al. have recently shown the in vitro ability of the OTC to induce a
significant interferon (IFN)‐γ release from human T lymphocytes and non‐T cells [9].
Besides the ability to induce mortality of both the T lymphocytes and non‐T cells after a 48‐h
co‐incubation, OTC was also able to induce the release of pro‐inflammatory cytokines in the
first 10–12 h of challenging. More in detail, T lymphocytes increased their IFN‐γ production
once exposed to OTC or to the culture media conditioned with the bone derived by OTC‐
treated chickens in order to resemble the same conditions of intensive farming [15].
Both the innate immunity (non‐T cells, mainly represented by natural killer (NK) lymphocytes)
and the acquired immunity (T lymphocytes, CD8+, and CD4+) [19, 20] resulted to be influenced
by the OTC toxicity (Figure 2).
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Figure 1. Percentage of PBMC undergoing apoptosis. On the x‐axis, different cell incubations and conditioned cell
culture medium dilutions, after 12h (B) and 24h (A) of incubation, are shown. OTC‐CCM indicates the conditioned cell
culture medium challenged with a ground bone of chickens treated with OTC; the C‐CCM indicates the growth medi‐
um challenged with a ground bone of chickens treated without OTC, while OTC alone indicates a growth medium
with the addition of 1 μg/ml of OTC. The “ctr” indicates the incubation in the growth medium with Annexin V stain‐
ing, which has been used as a control of the apoptosis that occurs in the cells when in a culture without any other
incubation is maintained; **p < 0.01, and ***p < 0.001 (with the permission of John Wiley and Sons) [18].
Figure 2. Percentage of IFN‐γ production in CD4+ and CD8+ T lymphocytes and in non‐T cells. The bar column
graphs represent the mean values of the percentage of IFN‐γ‐producing cells. On the x‐axis, different cell incubations
and conditioned cell culture medium dilutions are shown. OTC‐CCM indicates the conditioned cell culture medium
challenged with a ground bone of chickens treated with OTC; the C‐CCM indicates the growth medium challenged
with a ground bone of chickens treated without OTC, while OTC alone indicates a growth medium with the addition
of 1 μg/ml of OTC. The condition indicates as “ctr” refers to basal IFN‐γ production. All the cell cultures (ctr, OTC
alone, OTC‐CCM, and C‐CCM) were maintained in a growth medium added with PMA and ionomycin to induce cyto‐
kine production. Panels A, B, and C show IFN‐γ production in CD4+ T lymphocytes, CD8+ T lymphocytes, and in non‐
T cells, respectively; *p < 0.05, **p < 0.01, and ****p < 0.001 (with the permission of John Wiley and Sons) [18].
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In this context, it is known that IFN‐γ represents the main cytokine involved in the immune
response [21], as well as a crucial element in the onset of impaired tissue homeostasis condi‐
tions, typically related to autoimmunity or chronic inflammation [22–30].
These observations clearly reinforce the potential toxicity associated with chronic consumption
of poultry bones and derivatives by pets and pave the way for a new concept of food sensiti‐
zation due to contaminant presence as main enhancers of inflammatory processes, which
typically characterize skin and gastrointestinal diseases. Although the Food and Drug
Administration [31] and World Health Organization [32] have recently established maximum
residue limits in foods, antibiotic residues in foods may still be present [33] thus explaining
the persistence of dermatological manifestations in many pets. Moreover, international laws
do not impose an antibiotic concentration evaluation in bones and fat, which are considered
inedible, thus making pet food dangerous for pet's health [34].
A wide number of scientific reports suggest the possible toxicity and harmfulness of OTC
toward human and pet health as a consequence of the consumption of meat derived from
intensive farming [15, 35–40].
All of these data may explain why chicken proteins, widely considered hypoallergenic and
highly effective from a dietary point of view, play an important role in the etiology of several
inflammatory pathologies. It is worth noting that the similarities between these phenomena
and food allergies, atopy, and Flea allergy dermatitis have been observed. In spite of the limited
evidence that canine food allergy is suggested to resemble a type I hypersensitivity reaction
to allergens ingested by food, it cannot be excluded that non‐IgE‐mediated food allergies may
also occur. Although literature reports have been evidenced that the prevalence of food
allergies in dogs and cats is still unknown, the impressive number of cases is not justified merely
on the basis of increased allergy spreading in civilized societies. Furthermore, it has been
observed that 25% of the cats with both chronic GI and skin problems do not clinically express
food allergies, while the remaining 75% had only gastrointestinal problems. On the other hand,
there are no data regarding food allergies related to gastrointestinal problems in dogs. In
addition, food allergies can be often confused with pyoderma, pruritic exudative dermatitis
or “hot spots.”
Based on our recent studies, we investigated the sera of 24 dogs with food‐adverse reactions,
that is, itching, diarrhea, otitis, dermatitis, conjunctivitis, overnight fasting, vomiting, flatu‐
lence, interdigital pyoderma, and anal sacs repletion for the presence of any haptens which
might be responsible for such conditions by means of an enzyme‐linked immunosorbent assay
(ELISA) (FS0059, IDLABS™ Inc. Biotechnology, PO Box 1145, Station CSC, London ON N6A
5K2, Canada) according to the manufacturer's instructions [12].
Results indicated the presence of OTC and doxycycline in all animal sera. Although only eight
out of 24 dogs (33%) showed antibiotic concentrations above the ELISA detection limit (7.5 ng/
ml or ppb), all the remaining dogs presented serum levels of both antibiotics. OTC serum levels
ranged from 2.61 to 56.04 ng/ml (6.30 ± 2.12; mean ± standard error of the mean), whereas
doxycycline serum levels ranged from 1.28 to 22.84 ng/ml (5.20 ± 0.89; mean ± standard error
of the mean). Our preliminary clinical investigation further confirmed the haptenic toxic‐
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sensitizing mechanism due to prolonged subliminal oral intake of OTC‐enriched bone‐meal‐
based feeds derived from animals grown under a chronic tetracycline administration regime.
3. Herbal extracts: possible pets’ health allies
What differentiates common pet food from a functional pet food is the presence of a protein
source free of any contaminants, for example, antibiotics and hormones (as happens in
intensive farming) as well as the addition of antioxidants, minerals, trace elements, herbal
extracts, and medical plants in order to, respectively, stabilize, preserve, and improve the whole
nutritional profile of the food.
Many scientific studies clearly demonstrate the efficacy of functional herbal extracts or medical
plants for disease prevention or treatment, to improve overall health status or even to delay
aging [41].
Based on these observations, we recently studied the anti‐inflammatory and antitoxic activity
of a well‐standardized mixed pool of herbal extracts, as part of a commercially available pet
food diet, following an OTC challenge [42]. More in detail, the extracts within the pool were
Ascophyllum nodosum (66.3%), Cucumis melo (1.5%), Carica papaya (3.1%), Aloe vera (3.1%),
Haematococcus pluvialis (1.1%), Curcuma longa (2.3%), Camellia sinensis (1.5%), Punica granatum
(1.5%), Piper nigrum (0.6%), Polygonum cuspidatum (1.5%), Echinacea purpurea (3.1%), Grifola
frondosa (6.3%), and Glycine max (4.6%).
As previously explained, OTC is able to induce a significant IFN‐γ release from human T
lymphocyte and non‐T cell [9] in vitro. Here, we demonstrated that this significant release was
significantly reduced after a 24‐h individual co‐incubation of human T lymphocyte and non‐
T cells with all aforementioned extracts with the only exception of A. vera (Figure 3).
Further, we reported the same antitoxic and anti‐inflammatory activity of these extracts, with
the only exception of C. papaya and with P. nigrum, on canine T lymphocytes challenged with
OTC (Figure 4).
The antitoxic and anti‐inflammatory activity exerted by the extracts represents a further proof
of the usefulness of the addition of selected and standardized herbal extracts within a pet food
possibly free of any contaminant. In this way, it is possible to achieve a functional pet food able
to support and enhance standard pharmacological treatments in the presence of infections or
inflammatory diseases.
However, it is worth noting that enzyme deficiencies or different metabolic pathways make
some plants, for example, onions, leeks, garlic, and chives, toxic for dogs and cats but not for
humans [43]. For instance, one of the toxic effects of these plants is the oxidative hemolysis,
which results from the inability of the antioxidant metabolic pathways to counteract an excess
of oxidants in the erythrocytes. The toxicological mechanism is the following: (1) oxidation of
the exposed β‐93 cysteine residues present in the hemoglobin and consequent sulfhemoglobin
formation, (2a) precipitation, aggregation, and binding of sulfhemoglobin to the cell mem‐
brane and formation of the Heinz bodies, and (2b) membrane cross‐linking reactions occurring
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and eccentrocyte formation, (3) erythrocyte fragility increase and consequent extravascular
hemolysis, (4) decreased blood oxygen transportation capacity, and (5) impaired delivery of
oxygen to the tissues [44–46].
Figure 3. The effects of botanicals on cytokine production by human PBMCs. (a) shows the gating on viable lympho‐
cytes (R1 in dot plot graph) based on FSC and SSC parameters (see Section 2); (b) represents the gating on TH lympho‐
cytes (CD3+ CD8‐ as R2 in the dot plot graph) and on non‐T cells (CD3‐ CD8‐ cells as R3 in the dot plot graph); and (c)
shows the IFN‐γ and IL‐4 production in human TH lymphocytes and non‐T cells incubated with ad hoc medium de‐
rived from botanicals or from mixture (see Section 2). Cytokine production was evaluated as percentage of IFN‐γ (y‐
axis) and IL‐4 (x‐axis)‐producing cells. The percentage of IFN‐γ (upper left quadrant inside the dot plots) and IL‐4
(lower right quadrant inside the dot plots)‐producing CD4 T (R2) and non‐T (R3) cells is reported. The different cell
incubations with ad hoc medium derived from botanicals or from mixture (see Section 2) are indicated on top of each
graph. (d) reports the statistic representation of 10 experiments on human CD4+ T lymphocytes evaluated as percent‐
age of IFN‐γ‐producing cells, *p < 0.05. The different cell incubations with ad hoc medium derived from botanicals or
from mixture (see Section 2) are indicated on top of each column. The abbreviation “ctr” in (c) and (d) indicates the
basal cytokine production by PMBCs stimulated by PMA and ionomycin and in the presence of the ad hoc medium
based on the same solubilizing vehicle but free from the botanicals (see Section 2); specifically, ctr 1 (Ascophyllum n.,
Carica p., Aloe v., Cucumis m., Glycine m., and Grifola f.), ctr 2 (Echinacea p., Piper n.), ctr 3 (Haematococcus p.), and ctr 4 (the
mixture of all the botanicals) (with the permission of Hindawi) [42].
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Figure 4. The effects of botanicals on IFN‐γ production by canine PBMCs. (a) shows the gating on viable lympho‐
cytes (R1 in dot plot graph) based on FSC and SSC parameters (see Section 2). (b) represents the gating on CD4+ T lym‐
phocytes (CD3+ CD8‐ as R2 in the dot plot graph). (c) reports the results from one representative experiment showing
the percentage (the number in upper quadrant) of IFN‐γ‐producing canine CD4+ T lymphocytes gated on R2 (y‐axis);
x‐axis indicates the SSC parameter (see Section 2). The different co‐incubations of cells with ad hoc medium or mixture
(see Section 2) are indicated on the top. (d) shows the statistic representation of the IFN‐γ production by canine CD4+ T
lymphocytes evaluated as percentage of IFN‐γ‐producing cells in 10 representative experiments, *p < 0.05. The abbrevi‐
ation “ctr” in (c) and (d) indicates the basal IFN‐γ production by PMBCs stimulated by PMA and ionomycin and in the
presence of the ad hoc medium based on the same solubilizing vehicle but free from the botanicals (see Section 2):
specifically, ctr 1 (Ascophyllum n., Carica p., Aloe v., Cucumis v., Glycine m., and Grifola f.), ctr 2 (Echinacea p., Piper n.), and
ctr 3 (Haematococcus p.) (with the permission of Hindawi) [42].
This phenomenon can be obviously exacerbated in the presence of heritable high erythrocyte‐
reduced glutathione and potassium concentrations or glucose‐6‐phosphate dehydrogenase
deficiency or zinc deficiency [47, 48].
Thus, dietary supplements, home‐made or commercially available pet food containing some
plants or herbal extracts, might transform a functional food into a poisoning food.
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4. Pet diets and animal well‐being
Some scientific evidence has pointed out the efficacy of selected ingredients, as part of a
commercially available diet, in relieving inflammatory conditions in pets by means of an
immune modulatory and antioxidant activity [49–57].
Pasquini et al. [53] demonstrated that dogs fed a specific diet (F10 Maxi Maintenance®) based
on maize, fish meal (20%), maize oil, fish oil, brewer's yeast, beet pulp, minerals, MOS, FOS,
Elaeis guineensis, Yucca schidigera, C. papaya, Ananas spp., P. granatum, Panax ginseng, and
Rosmarinus officinalis was able to influence gender, age, and breed‐derived lipid metabolism
alterations in healthy dogs by significantly decreasing C‐tot, C‐high‐density lipoprotein (HDL),
and C‐low‐density lipoprotein (LDL) (*p < 0.05) [57].
Further studies have then clearly demonstrated the synergic efficacy of selected ingredients
in modulating several inflammatory conditions, which commonly affect pets, especially dogs
[49–52, 56, 58].
An inflammatory condition can also occur during food allergy reactions, which usually takes
place after the intake of a harmless dietary component [59]. Generally, food‐allergic reactions
in pets include cutaneous (flush, itching, dandruff, skin malodor, dry fur, and skin lesions) and
gastrointestinal manifestations (dehydration, appetite loss, regurgitation, emesis, abdominal
pain, flatulence, borborygma, diarrhea, weight loss, stool consistency, blood, and mucus
presence in the stool) [56].
Based on these observations, we conducted two different clinical evaluations aimed to validate
two different commercially available formulas for aforementioned dermatological and
gastrointestinal issues. For instance, a mixture of fish, potato, A. vera, Arctium lappa, Malva
sylvestris, and Ribes nigrum (FORZA10 Dermo ActiveTM) resulted particularly effective in
halving the intensity of cutaneous symptoms (flush, itch, dandruff, skin malodor, dry fur, and
skin lesions) in 71 dogs affected by atopic dermatitis (***p < 0.001) [56]. On the other hand, a
specific diet consisting of a mixture of milk enzymes, Origanum vulgare, chestnut, Plantago
psyllium, MOS, FOS, electrolytes, and Rosa canina, significantly reduced the intensity of
symptoms (dehydration, appetite loss, regurgitation, emesis, abdominal pain, flatulence,
borborygma, diarrhea, weight loss, stool consistency, blood, and mucus presence in the stool)
in 60 dogs with evident gastrointestinal issues (***p < 0.001) [56]. Obviously, an inflammatory
condition may also occur in other segments of the gastrointestinal apparatus, such as the
mouth. In this case, the main clinical manifestation is halitosis, which is generally the sum of
metabolic anomalies, poor oral hygiene, hyposalivation, dental appliances, as well as gingival,
mucosal, and periodontal disease [60]. In this regard, pets can be affected by halitosis and a
correct dietary approach becomes fundamental to manage and treat such complaints [50, 61].
We compared the efficacy of a specific nutraceutical diet and a standard diet in significantly
reducing the concentration of three specific volatile sulfur compounds, hydrogen sulfide,
methyl mercaptans, and dimethyl sulfide, in 16 dogs suffering from chronic halitosis [50]. More
in detail, the diet consisted of a mixture of fish meal, rice carbohydrates, propolis, Salvia
officinalis, lysozyme, bioflavonoids, Thymus vulgaris, R. nigrum, and an Omega 3/6 ratio of 1:4.
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Then, by means of a portable gas chromatograph (OralChroma™), a syringe to collect the
breath and specific software, a significant reduction in halitosis, were observed after 30 days
from the beginning of the nutraceutical diet supplementation (*p < 0.05). Further, a long‐lasting
effect was still observed even 20 days after the diet interruption.
As previously stated, cats and dogs can be affected by adverse food reactions, which can involve
apparatuses including the gastroenteric and cutaneous but can be extended also to otological,
ocular, urinary, and respiratory systems [49, 62]. We recently ascertained the effectiveness of
a combined use of a nutraceutical diet and current pharmacological therapy in 15 adult dogs
affected by chronic bilateral otitis externa [49]. The diet, which was composed of fish proteins,
rice carbohydrates, Melaleuca alternifolia, Tilia platyphyllos scapoli et cordata, Allium sativum L.,
Rosa canina L. and Zinc and an Omega 3/6 ratio of 1:4, and the drug (Otomax®) significantly
reduced the mean intensity of all clinical symptoms (occlusion of ear canal, erythema,
discharge quantity, and odor) within 90 days (***p < 0.001). This study can be considered a
further example of the importance of the selection of substances endowed with anti‐inflam‐
matory and antioxidant activity in a pet food diet.
In some cases, substances endowed with anti‐inflammatory as well as immune‐modulatory
activity can drastically influence the clinical outcome of lethal pathologies, that is, Leishmania
[63].
A study conducted by Cortese et al. investigated the effect of an immune‐modulating diet,
based on fish‐ and vegetable‐hydrolyzed proteins, minerals, A. nodosum, C. melo, C. papaya, A.
vera, Astaxanthin, C. longa, C. sinensis, P. granatum, P. nigrum, Poligonum spp., E. purpurea, G.
frondosa, G. max and an Omega 3/6 ratio of 1:1 along with an anti‐Leishmania pharmacological
therapy (meglumine antimoniate, and allopurinol) in 20 naturally infected dogs over a period
of 12 months [63]. The diet results were particularly effective in restoring regulatory T cells
and decreasing T helper cell percentage (***p < 0.001).
In other cases, the selection of substances with a remarkable antioxidant activity also acquires
a pivotal role in other clinical conditions, which are not strictly related to adverse food
reactions, that is, cognitive impairment, as a consequence of aging or pathologies such as
Alzheimer's and Parkinson's disease [52, 64, 65].
In this regard, we studied the effect of a nutraceutical diet based on fish proteins, rice carbo‐
hydrates, G. frondosa, C. longa, C. papaya, P. granatum, A. vera, P. cuspidatum, Solanum lycopersi‐
cum, Vitis vinifera, R. officinalis, and an Omega 3/6 ratio of 1:0.8 on cognitive decline of nine
elderly dogs over a period of 6 months [52]. Specifically, derivatives of reactive oxygen
metabolites, biological antioxidant potential levels, and brain‐derived neurotrophic factor
were evaluated in dogs’ plasma samples at the beginning and at the end of the dietary regime.
Results showed a significant decrease of dROMs (*p < 0.05) and a significant increase in brain‐
derived neurotropic factor (BDNF) (*p < 0.05) serum levels.
A recent study has also raised the possible key role of some selected ingredients (fish proteins,
rice carbohydrates, P. granatum, Valeriana officinalis, R. officinalis, Tilia spp., tea extract, and l‐
tryptophan, with an Omega‐3:‐6 ratio of 1:0.8) in modulating behavioral disturbances in 12
dogs with chronic anxiety and stress caused by intense and restless activity over a period of
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only 10 days [58]. By means of a sophisticated and extremely sensitive sensor, a mobile phone
app, and a wireless router, it was possible to induce and monitor significant improvements in
the time spent in activity and at rest (**p < 0.01 and *p < 0.05, respectively). Last but not least,
all dogs also showed an overall significant improvement in clinical (dandruff, itchiness, flush,
seborrhea, fur opacity, vomiting, diarrhea, flatulence, lachrymation, and anal sac repletion)
and behavioral (marking, anxiety, diffidence, irregular biorhythm, reactivity, activation,
irritability, alertness, environmental exploration, and attention requirement) symptoms.
5. The “market stand” of functional pet foods
The interest into the adequacy and safety of commercially available pet foods has been growing
worldwide [66]. Functional foods such as prebiotics, for example, inulin, gluco‐oligosacchar‐
ides, and galacto‐oligosaccharides have shown to induce beneficial effects on biochemical
parameters improving satiety and reducing postprandial glucose and insulin concentrations,
thus reducing diabetes‐related disorders [67–69]. Inulin and oligofructose, but also dietary
fibers, can also modify the intestinal microflora in pets and humans by promoting commensal
bacteria growth [70–72]. However, many in vitro studies highlighted other hidden properties
of dietary fibers such as gastric emptying, gastric transit time and decrease in blood cholesterol
concentrations, increase in satiety, glucose uptake rate, and fecal excretion as well as dilution
in diet calorie density [73–76]. Another valuable fiber source is represented by corn fiber due
to the lack of detrimental effects on palatability and nutrient digestibility, and the glycemic
response lowering in adult dogs [71, 77]. Based on these novel and unexpected activities of
dietary fibers, many commercially available pet diets moved to an accurate use of these along
with novel sources of carbohydrates including cereal grains, which represents almost 90% of
animal diet content, and whole grains [78]. These latter, whose main source are wheat, corn,
oats, barley, and rye [79], are rich in dietary fibers, trace minerals, and vitamins B and E [80].
Furthermore, whole grains have bioactive compounds, for example, tocotrienols, lignans and
polyphenols, lipotropes and methyl donors, such as choline, methionine, betaine, inositol and
folate and antinutrients, that is, compounds that interfere with the absorption of nutrients such
as phytic acid, tannins, and saponins endowed with antioxidant and anti‐carcinogenic effect
[79–82]. As to rice bran, the vitamin‐rich outer layer that surrounds the endosperm of whole
grain brown rice has bioactive molecules such as tocopherols, tocotrienols, polyphenols
including ferulic acid and α‐lipoic acid, phytoesterols, γ‐oryzanol and carotenoids such as
carotene, lycopene, lutein, and zeaxanthin, which was endowed with antioxidant, anti‐
inflammatory, and chemopreventive activity [83]. Rice bran is also an excellent source of
essential amino acids (especially sulfur‐containing amino acids) and micronutrients such as
magnesium, manganese, and B‐vitamins (especially B9 and B12) [83, 84]. It is worth noting
that during pet food heat processing, known as the Maillard reaction, that is, a nonenzymatic
browning and flavoring reaction, a reduction of essential amino acids, such as lysine, bioa‐
vailability occurs [85, 86]. Therefore, many pet diets might be at the risk of supplying less lysine
than the animal may require. Hence, the understanding of nutritional benefits of functional
foods currently available is of key importance for the owners to provide their pets with the
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correct diet. Nevertheless, great attention has to be paid to pet food palatability along with
adequacy and safety. For instance, Spears and coworkers examined the palatability and its
effect on digestion of stabilized rice bran in a dry canine diet determining fecal characteristics,
food intake, selected immune mediators, and blood lipid characteristics [87]. They observed
that dry pet food containing 12% stabilized rice bran was well tolerated by dogs with no
detrimental effect on nutrient digestibility, fecal characteristics, and changes in inflammatory/
immune mediators. Moreover, the rice bran diet presented greater palatability compared to
the defatted rice bran diet. Vitamin A (retinol), whose safe upper limit in complete diets for
dogs ranges from 5.24 to 104.80 mmol, is an essential fat‐soluble vitamin at the center of
investigations in dogs in the context of immune stimulation, vision‐supporting functions,
reproduction, bone growth, and cellular differentiation [88–90]. In dogs, unlike humans where
retinyl esters are only detected in plasma in cases of intoxication or following a vitamin A‐rich
meal [91], vitamin A is present in the plasma predominantly in the form of retinyl esters, in
both adequate and vitamin A‐deprived states [92]. Moreover, in dogs [93], which excrete
vitamin A in the urine [91] along with retinyl esters [94], retinol concentrations are unaffected
by dietary vitamin A intake (1.2 ± 0.03 vs. 1.0 ± 0.03 mg/l, respectively), whereas serum retinyl
esters parallel the concentrations of vitamin A in the diet [91].
5.1. The role of microbiota
Pet's well‐being and health also depend on gut microbiota, whose composition and activity is
correlated to several diseases [95–97]. Cats and dogs harbor several bacterial species (with
Firmicutes, Bacteroidetes, Proteobacteria, Fusobacteria, and Eubacterium as the predominant phyla
[98–102]), which differ from each other but also from the same species [103]. As shown in
human studies, gut microbiota also plays a key role in immune and food intake regulation
[104, 105]. However, only a few studies have examined the impact of the diet on canine gut
microbial population [106–108]. For example, Kerr and coworkers evidenced the lack of
negative alterations of the microbiome in healthy dogs of different species (Golden Retriever,
Hound Mix, Pitbull Mix, Mixed, St. Bernard, Australian Cattle, Dalmatian, Pointer, Standard Poodle,
Terrier) fed on a cooked navy bean powder [109]. Cooked beans decreased Actinobacteria and
Fusobacteria and increased Firmicutes. Therefore, it is reasonable to think that future dietary
products for dogs will modulate the gut microbial population in order to treat or prevent some
food‐related diseases (dysbiosis, leaky gut, intestinal bowel disease, irritable bowel syndrome,
coeliac disease, sepsis, renal failure, autoimmune disease, peritonitis, and intestinal obstruc‐
tion). Recently, Park and coworkers monitored healthy dogs for 6 months [110]. The first group
was fed ad libitum on commercial food, while the second was fed on a restricted amount of the
same commercial food. Animals fed ad libitum resulted in obesity with high levels of trigly‐
cerides and cholesterol. The microbiota presented differences between the two groups of
animals, while Actinobacteria and Bacteroidetes were the predominant microflora in animals
receiving a restricted amount of food, animals fed ad libitum presented Firmicutes, Fusobacteria,
and Actinobacteria. Thus, a targeted diet may promote changes in gut microbiota affecting the
activity of specific beneficial microbes resulting in benefits for the overall dog's health. In this
sense, a targeted diet might also be based on the use of prebiotics, for example, chicory,
fructooligosaccharides, pectin, and polydextrose. Zentek and coworkers demonstrated that
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nine adult healthy beagles fed a diet supplemented with 3% chicory had more consistent stools
with increased levels of bifidobacteria and decreased Clostridium perfringens and a lower fecal
pH with respect to a protein‐rich diet [111]. Further, cats fed diet supplemented with FOS (4%
of diet) showed increased concentrations of bifidobacteria and reduced count of Escherichia
coli, while pectins (4% of diet) increased C. perfringens and lactobacilli concentrations [112].
Conversely, dogs fed a diet with low level of dietary fiber (beet pulp) for 2 weeks decreased
Fusobacteria and increased Firmicutes [107]. Interestingly, feline diets, particularly rich in animal
proteins and low‐carbohydrate plant‐based additives, promoted fecal Clostridium, Faecalibac‐
terium, Ruminococcus, Blautia, and Eubacterium growth affecting circulating hormones and
metabolites of key importance in satiety and host metabolism [113, 114]. As to polydextrose,
its consumption by dogs resulted in an increase of fecal acetate, propionate, and total SCFA
concentrations, while fecal pH, indole, and C. perfringens population decreased [106]. Thus,
incorporating prebiotics in pets’ diet may beneficially modulate gut microbiota and intestinal
health and possibly protect the animals from enteric infections.
6. Conclusions
Recent advances in pet food production have raised the potential of some functional ingredi‐
ents to be useful in preventing and treating disease in pets. Although further work is required
to better characterize the long‐term effect of these substances on biological mechanisms, we
reported some in vivo and in vitro examples of the synergic efficacy of selected ingredients,
present in some commercially available nutraceutical diets, as a valid and reliable natural
approach for the management of some pet diseases. Functional food development can be
considered a promising new research area, which surely will be able to improve the health and
quality of life of dogs and cats in the near future. However, great attention should be paid on
pet food production and ingredient selection since, without a correct R&D process, diets might
shift from the primary source of feeding to primary source of poisoning.
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